U.S., Aug. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07147218) titled 'Accelerated TMS for MDD' on Aug. 27.

Brief Summary: An open-label, multi-center, prospective study to evaluate feasibility and efficacy of accelerated TMS for patients with Major Depressive Disorder (MDD).

Study Start Date: Aug. 21

Study Type: INTERVENTIONAL

Condition: Major Depressive Disorder

Intervention: DEVICE: TMS

transcranial magnetic stimulation - DASH 36 treatment delivered in 5 days

Recruitment Status: RECRUITING

Sponsor: Neuronetics

Published by HT Digital Content Services with permission from Health Daily Digest....